Alejandra María Zúñiga-Muñoz

Prof. Alejandra María Zúñiga-Muñoz

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2014 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
RGRebeca Cambray Guerra
Rebeca Cambray Guerra
AZAlejandra María Zúñiga-Muñoz
Alejandra María Zúñiga-Muñoz
Veronica Guarner-LansVeronica Guarner-Lans
Veronica Guarner-Lans
EDEulises Díaz-Díaz
Eulises Díaz-Díaz
CBCarlos Alberto Tena Betancourt
Carlos Alberto Tena Betancourt
IPIsrael Pérez-Torres
Israel Pérez-Torres
The aim of this study was to evaluate the association between estrogen removal, antioxidant enzymes, and oxidative stress generated by obesity in a MS female rat model. Thirty two female Wistar rats were divided into 4 groups: Control (C), MS, MS ovariectomized (Ovx), and MS Ovx plus estradiol (E2). MS was induced by administering 30% sucrose to drinking water for 24 weeks. After sacrifice, intra-abdominal fat was dissected; adipocytes were isolated and lipid peroxidation, non-enzymatic antioxidant capacity, and the activities of Cu-Zn and Mn superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) were determined. There were no significant differences in the activities of Cu-Zn, Mn SOD, CAT, and GPx between the C and MS groups, but in the MS Ovx group there was a statistically significant decrease in the activities of these enzymes when compared to MS and MS Ovx+E2. The increased lipid peroxidation and nonenzymatic antioxidant capacity found in MS Ovx was significantly decreased when compared to MS and MS Ovx+E2. In conclusion, the removal of E2by ovariectomy decreases the activity of the antioxidant enzymes in the intra-abdominal tissue of MS female rats; this is reflected by increased lipid peroxidation and decreased nonenzymatic antioxidant capacity.

20 December 2024 in Biogerontology
Verified
Journal Article
Closed access
PDF file
RJRay Jiménez
Ray Jiménez
AZAlejandra María Zúñiga-Muñoz
Alejandra María Zúñiga-Muñoz
EÁEdith Álvarez-León
Edith Álvarez-León
WGWylly Ramsés García-Niño
Wylly Ramsés García-Niño
GNGabriela Navarrete-Anastasio
Gabriela Navarrete-Anastasio
APAlejandro Silva Palacios
Alejandro Silva Palacios

8 May 2013 in Clinical and Experimental Hypertension
Verified
Journal Article
Closed access
PDF file
IPIsrael Pérez-Torres
Israel Pérez-Torres
AZAlejandra María Zúñiga-Muñoz
Alejandra María Zúñiga-Muñoz
UBUlises Beltrán-Rodríguez
Ulises Beltrán-Rodríguez
EDEulises Díaz-Díaz
Eulises Díaz-Díaz
RMRaúl Martínez-Memije
Raúl Martínez-Memije
VLVerónica Guarner Lans
Verónica Guarner Lans
We investigated the effects of Hibiscus sabdariffa Linnaeus (HSL)-fed infusion on the fatty acid (FA) profile in liver of metabolic syndrome (MS) rats and its possible effect on vascular reactivity. Body mass, intra-abdominal fat, triglycerides, insulin, blood pressure, saturated, monounsaturated FA, NEFAs, Δ9-, Δ6-desaturases and vasoconstriction were increased, while vasorelaxation, polyunsaturated FA, endothelial nitric oxide and / ratio decreased in MS versus Control, but HSL infusion modified it and increased Δ5-desaturase. The results suggest that the alteration in FA liver metabolism in the MS contributes to impaired vascular reactivity, but treatment with of HSL infusion can improve this condition.

1 December 2019 in Cellular Signalling
Verified
Journal Article
Closed access
JDJorge-Luis Díaz-Ruíz
Jorge-Luis Díaz-Ruíz
AMArturo Macías-López
Arturo Macías-López
FAFrancisco Alcalá-Vargas
Francisco Alcalá-Vargas
JGJosé-Guadalupe Guevara-Chávez
José-Guadalupe Guevara-Chávez
AMAída Mejía-Uribe
Aída Mejía-Uribe
Mabel Buelna-ChontalMabel Buelna-Chontal
Mabel Buelna-Chontal

1 January 2016 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
IPIsrael Pérez-Torres
Israel Pérez-Torres
Veronica Guarner-LansVeronica Guarner-Lans
Veronica Guarner-Lans
AZAlejandra María Zúñiga-Muñoz
Alejandra María Zúñiga-Muñoz
RERodrigo Velázquez Espejel
Rodrigo Velázquez Espejel
ACAlfredo Cabrera-Orefice
Alfredo Cabrera-Orefice
NPNatalia Pavón
Natalia Pavón
We report the effect of cross‐sex hormonal replacement on antioxidant enzymes from rat retroperitoneal fat adipocytes. Eight rats of each gender were assigned to each of the following groups: control groups were intact female or male (F and M, resp.). Experimental groups were ovariectomized F (OvxF), castrated M (CasM), OvxF plus testosterone (OvxF + T), and CasM plus estradiol (CasM + E2) groups. After sacrifice, retroperitoneal fat was dissected and processed for histology. Adipocytes were isolated and the following enzymatic activities were determined: Cu‐Zn superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione‐S‐transferase (GST), and glutathione reductase (GR). Also, glutathione (GSH) and lipid peroxidation (LPO) were measured. In OvxF, retroperitoneal fat increased and adipocytes were enlarged, while in CasM rats a decrease in retroperitoneal fat and small adipocytes are observed. The cross‐sex hormonal replacement in F rats was associated with larger adipocytes and a further decreased activity of Cu‐Zn SOD, CAT, GPx, GST, GR, and GSH, in addition to an increase in LPO. CasM + E2 exhibited the opposite effects showing further activation antioxidant enzymes and decreases in LPO. In conclusion, E2 deficiency favors an increase in retroperitoneal fat and large adipocytes. Cross‐sex hormonal replacement in F rats aggravates the condition by inhibiting antioxidant enzymes.

27 September 2015 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
AZAlejandra María Zúñiga-Muñoz
Alejandra María Zúñiga-Muñoz
Veronica Guarner-LansVeronica Guarner-Lans
Veronica Guarner-Lans
Elizabeth Soria-CastroElizabeth Soria-Castro
Elizabeth Soria-Castro
EDE. Diaz-Diaz
E. Diaz-Diaz
RTR. Torrico-Lavayen
R. Torrico-Lavayen
IPIsrael Pérez-Torres
Israel Pérez-Torres
Prevalence of metabolic syndrome and progression of nephropathy depend on sex. We examined a protective effect of estradiol against nephropathy in metabolic syndrome through the modulation of the arachidonic acid metabolism by activating the 5-lipoxygenase and cytochrome p450 4A pathways. 28 female Wistar rats were divided into four groups of seven animals each: control, intact metabolic syndrome, ovariectomized metabolic syndrome, and metabolic syndrome ovariectomized plus estradiol. Blood pressure, body weight, body fat, triglycerides, insulin, HOMA-index, albuminuria, and TNF-αwere increased in ovariectomized metabolic syndrome rats (p<0.001). The perfusion pressure in isolated kidneys of ovariectomized metabolic syndrome rats in presence of 4 μg of arachidonic acid was increased. The inhibitors of the arachidonic acid metabolism Baicalein, Miconazole, and Indomethacin in these rats decreased the perfusion pressure by 57.62%, 99.83%, and 108.5%, respectively and they decreased creatinine clearance and the arachidonic acid percentage. Phospholipase A2expression in the kidney of ovariectomized metabolic syndrome rats was not modified. 5-lipoxygenase was increased in metabolic syndrome ovariectomized rats while cytochrome p450 4A was decreased. In conclusion, the loss of estradiol increases renal damage while the treatment with estradiol benefits renal function by modulating arachidonic acid metabolism through the 5-lipoxygenase and cytochrome p450 4A pathways.